OCUL Price / Book | OCULAR THERAPEUTIX, INC

OCULAR THERAPEUTIX, INC (OCUL) Price / Book

2026-09-03: Price/Book Ratio 4.49.
2026-06-30: Price/Book Ratio 4.15.
2026-03-31: Price/Book Ratio 3.19.
2025-12-31: Price/Book Ratio 4.01.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-09-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	4.49
2026-06-30	4.15
2026-03-31	3.19
2025-12-31	4.01
2025-09-30	7.92
2025-06-30	5.25
2025-03-31	4.39
2024-12-31	4.27
2024-09-30	3.87
2024-06-30	2.82
2024-03-31	3.45
2023-12-31	5.63
2023-09-30	31.75
2023-06-30	132.44
2023-03-31	42.07
2022-12-31	6.13
2022-09-30	6.91
2022-06-30	4.7
2022-03-31	4.76
2021-12-31	6.08
2021-09-30	8.77
2021-06-30	13.51
2021-03-31	15
2020-12-31	20.67
2020-06-30	98.13
2019-09-30	12.93
2019-06-30	23.5
2019-03-31	6.63
2018-12-31	4.61
2018-09-30	6.13
2018-06-30	5.68
2018-03-31	4.93
2017-12-31	5.05
2017-09-30	5.06
2017-06-30	5.61
2017-03-31	4.2
2016-12-31	4.03
2016-09-30	2.74
2016-06-30	1.74
2016-03-31	2.98
2015-12-31	2.59
2015-09-30	3.52
2015-06-30	4.76
2015-03-31	17.28
2014-12-31	8.55
2014-09-30	4.87

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Prestige Consumer Healthcare Inc. (PBH)	United States	$2.163B	13.03
Bausch Health Companies Inc. (BHC)		$2.113B	-1.68
Aurinia Pharmaceuticals Inc. (AUPH)		$2.207B	7.18
Braveheart Bio, Inc. (BRVE)	United States	$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
Zai Lab Ltd (ZLAB)		$2.241B	-113.34
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
NEKTAR THERAPEUTICS (NKTR)	United States	$2.026B	-9.05